4
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

4
U.S. (TOLL FREE)
+1 (315) 215-3225
Global COVID-19 Diagnostic Testing Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-32B5773
Home | Market Reports | Health| Nursing
Global COVID 19 Diagnostic Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global COVID-19 Diagnostic Testing Market Insights, Forecast to 2030

Code: QYRE-Auto-32B5773
Report
December 2024
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

COVID-19 Diagnostic Testing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

COVID-19 Diagnostic Testing Market

COVID-19 Diagnostic Testing Market

COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Market Analysis and Insights: Global COVID-19 Diagnostic Testing Market
The global COVID-19 Diagnostic Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for COVID-19 Diagnostic Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of COVID-19 Diagnostic Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for COVID-19 Diagnostic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the COVID-19 Diagnostic Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global COVID-19 Diagnostic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for COVID-19 Diagnostic Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of COVID-19 Diagnostic Testing Market Report

Report Metric Details
Report Name COVID-19 Diagnostic Testing Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of COVID-19 Diagnostic Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of COVID-19 Diagnostic Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COVID-19 Diagnostic Testing revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the COVID-19 Diagnostic Testing Market report?

Ans: The main players in the COVID-19 Diagnostic Testing Market are Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, Dynamiker Biotechnology (Tianjin), ADVAITE

What are the Application segmentation covered in the COVID-19 Diagnostic Testing Market report?

Ans: The Applications covered in the COVID-19 Diagnostic Testing Market report are Hospitals, Scientific Research

What are the Type segmentation covered in the COVID-19 Diagnostic Testing Market report?

Ans: The Types covered in the COVID-19 Diagnostic Testing Market report are Nucleic Acid Testing, Antibody Testing

Recommended Reports

COVID Diagnostics

COVID Vaccine Market

Broader Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Nucleic Acid Testing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global COVID-19 Diagnostic Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Diagnostic Testing Market Perspective (2019-2030)
2.2 Global COVID-19 Diagnostic Testing Growth Trends by Region
2.2.1 COVID-19 Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 COVID-19 Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 COVID-19 Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 COVID-19 Diagnostic Testing Market Dynamics
2.3.1 COVID-19 Diagnostic Testing Industry Trends
2.3.2 COVID-19 Diagnostic Testing Market Drivers
2.3.3 COVID-19 Diagnostic Testing Market Challenges
2.3.4 COVID-19 Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue COVID-19 Diagnostic Testing by Players
3.1.1 Global COVID-19 Diagnostic Testing Revenue by Players (2019-2024)
3.1.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of COVID-19 Diagnostic Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global COVID-19 Diagnostic Testing Market Concentration Ratio
3.4.1 Global COVID-19 Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Diagnostic Testing Revenue in 2023
3.5 Global Key Players of COVID-19 Diagnostic Testing Head office and Area Served
3.6 Global Key Players of COVID-19 Diagnostic Testing, Product and Application
3.7 Global Key Players of COVID-19 Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Diagnostic Testing Breakdown Data by Type
4.1 Global COVID-19 Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 COVID-19 Diagnostic Testing Breakdown Data by Application
5.1 Global COVID-19 Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America COVID-19 Diagnostic Testing Market Size (2019-2030)
6.2 North America COVID-19 Diagnostic Testing Market Size by Type
6.2.1 North America COVID-19 Diagnostic Testing Market Size by Type (2019-2024)
6.2.2 North America COVID-19 Diagnostic Testing Market Size by Type (2025-2030)
6.2.3 North America COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
6.3 North America COVID-19 Diagnostic Testing Market Size by Application
6.3.1 North America COVID-19 Diagnostic Testing Market Size by Application (2019-2024)
6.3.2 North America COVID-19 Diagnostic Testing Market Size by Application (2025-2030)
6.3.3 North America COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
6.4 North America COVID-19 Diagnostic Testing Market Size by Country
6.4.1 North America COVID-19 Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America COVID-19 Diagnostic Testing Market Size by Country (2019-2024)
6.4.3 North America COVID-19 Diagnostic Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe COVID-19 Diagnostic Testing Market Size (2019-2030)
7.2 Europe COVID-19 Diagnostic Testing Market Size by Type
7.2.1 Europe COVID-19 Diagnostic Testing Market Size by Type (2019-2024)
7.2.2 Europe COVID-19 Diagnostic Testing Market Size by Type (2025-2030)
7.2.3 Europe COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
7.3 Europe COVID-19 Diagnostic Testing Market Size by Application
7.3.1 Europe COVID-19 Diagnostic Testing Market Size by Application (2019-2024)
7.3.2 Europe COVID-19 Diagnostic Testing Market Size by Application (2025-2030)
7.3.3 Europe COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
7.4 Europe COVID-19 Diagnostic Testing Market Size by Country
7.4.1 Europe COVID-19 Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe COVID-19 Diagnostic Testing Market Size by Country (2019-2024)
7.4.3 Europe COVID-19 Diagnostic Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China COVID-19 Diagnostic Testing Market Size (2019-2030)
8.2 China COVID-19 Diagnostic Testing Market Size by Type
8.2.1 China COVID-19 Diagnostic Testing Market Size by Type (2019-2024)
8.2.2 China COVID-19 Diagnostic Testing Market Size by Type (2025-2030)
8.2.3 China COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
8.3 China COVID-19 Diagnostic Testing Market Size by Application
8.3.1 China COVID-19 Diagnostic Testing Market Size by Application (2019-2024)
8.3.2 China COVID-19 Diagnostic Testing Market Size by Application (2025-2030)
8.3.3 China COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia COVID-19 Diagnostic Testing Market Size (2019-2030)
9.2 Asia COVID-19 Diagnostic Testing Market Size by Type
9.2.1 Asia COVID-19 Diagnostic Testing Market Size by Type (2019-2024)
9.2.2 Asia COVID-19 Diagnostic Testing Market Size by Type (2025-2030)
9.2.3 Asia COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
9.3 Asia COVID-19 Diagnostic Testing Market Size by Application
9.3.1 Asia COVID-19 Diagnostic Testing Market Size by Application (2019-2024)
9.3.2 Asia COVID-19 Diagnostic Testing Market Size by Application (2025-2030)
9.3.3 Asia COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
9.4 Asia COVID-19 Diagnostic Testing Market Size by Region
9.4.1 Asia COVID-19 Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia COVID-19 Diagnostic Testing Market Size by Region (2019-2024)
9.4.3 Asia COVID-19 Diagnostic Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Diagnostic Testing Introduction
11.1.4 Cellex Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.1.5 Cellex Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Diagnostic Testing Introduction
11.2.4 Abbott Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.2.5 Abbott Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Diagnostic Testing Introduction
11.3.4 Roche Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.3.5 Roche Recent Developments
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Diagnostic Testing Introduction
11.4.4 BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.4.5 BioMedomics Recent Developments
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Diagnostic Testing Introduction
11.5.4 BD Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.5.5 BD Recent Developments
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Diagnostic Testing Introduction
11.6.4 Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.6.5 Henry Schein Recent Developments
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.7.5 Safecare Bio-Tech Recent Developments
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Details
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Introduction
11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.8.5 Mayo Clinic Laboratories Recent Developments
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Details
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Introduction
11.9.4 Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.9.5 Chembio Diagnostics Recent Developments
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Details
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Introduction
11.10.4 Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.10.5 Mount Sinai Laboratory Recent Developments
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.11.5 Ortho Clinical Diagnostics Recent Developments
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Details
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.12.5 Zhejiang Orient Gene Biotech Recent Developments
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Details
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Introduction
11.13.4 Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.13.5 Innovita Biological Technology Recent Developments
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Details
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.14.5 Guangzhou Wondfo Biotech Recent Developments
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Details
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.15.5 Guangdong Hecin-Scientific Recent Developments
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Details
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
11.17 ADVAITE
11.17.1 ADVAITE Company Details
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 Diagnostic Testing Introduction
11.17.4 ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2019-2024)
11.17.5 ADVAITE Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Nucleic Acid Testing
    Table 3. Key Players of Antibody Testing
    Table 4. Global COVID-19 Diagnostic Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global COVID-19 Diagnostic Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global COVID-19 Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global COVID-19 Diagnostic Testing Market Share by Region (2019-2024)
    Table 8. Global COVID-19 Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global COVID-19 Diagnostic Testing Market Share by Region (2025-2030)
    Table 10. COVID-19 Diagnostic Testing Market Trends
    Table 11. COVID-19 Diagnostic Testing Market Drivers
    Table 12. COVID-19 Diagnostic Testing Market Challenges
    Table 13. COVID-19 Diagnostic Testing Market Restraints
    Table 14. Global COVID-19 Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global COVID-19 Diagnostic Testing Revenue Share by Players (2019-2024)
    Table 16. Global Top COVID-19 Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Testing as of 2023)
    Table 17. Global COVID-19 Diagnostic Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by COVID-19 Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of COVID-19 Diagnostic Testing, Headquarters and Area Served
    Table 20. Global Key Players of COVID-19 Diagnostic Testing, Product and Application
    Table 21. Global Key Players of COVID-19 Diagnostic Testing, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global COVID-19 Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2019-2024)
    Table 25. Global COVID-19 Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global COVID-19 Diagnostic Testing Revenue Market Share by Type (2025-2030)
    Table 27. Global COVID-19 Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global COVID-19 Diagnostic Testing Revenue Share by Application (2019-2024)
    Table 29. Global COVID-19 Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global COVID-19 Diagnostic Testing Revenue Share by Application (2025-2030)
    Table 31. North America COVID-19 Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America COVID-19 Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America COVID-19 Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America COVID-19 Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America COVID-19 Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America COVID-19 Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America COVID-19 Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe COVID-19 Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe COVID-19 Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe COVID-19 Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe COVID-19 Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe COVID-19 Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe COVID-19 Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe COVID-19 Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China COVID-19 Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China COVID-19 Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China COVID-19 Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China COVID-19 Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia COVID-19 Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia COVID-19 Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia COVID-19 Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia COVID-19 Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia COVID-19 Diagnostic Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia COVID-19 Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia COVID-19 Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Cellex Company Details
    Table 64. Cellex Business Overview
    Table 65. Cellex COVID-19 Diagnostic Testing Product
    Table 66. Cellex Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 67. Cellex Recent Developments
    Table 68. Abbott Company Details
    Table 69. Abbott Business Overview
    Table 70. Abbott COVID-19 Diagnostic Testing Product
    Table 71. Abbott Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 72. Abbott Recent Developments
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche COVID-19 Diagnostic Testing Product
    Table 76. Roche Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 77. Roche Recent Developments
    Table 78. BioMedomics Company Details
    Table 79. BioMedomics Business Overview
    Table 80. BioMedomics COVID-19 Diagnostic Testing Product
    Table 81. BioMedomics Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 82. BioMedomics Recent Developments
    Table 83. BD Company Details
    Table 84. BD Business Overview
    Table 85. BD COVID-19 Diagnostic Testing Product
    Table 86. BD Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 87. BD Recent Developments
    Table 88. Henry Schein Company Details
    Table 89. Henry Schein Business Overview
    Table 90. Henry Schein COVID-19 Diagnostic Testing Product
    Table 91. Henry Schein Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 92. Henry Schein Recent Developments
    Table 93. Safecare Bio-Tech Company Details
    Table 94. Safecare Bio-Tech Business Overview
    Table 95. Safecare Bio-Tech COVID-19 Diagnostic Testing Product
    Table 96. Safecare Bio-Tech Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 97. Safecare Bio-Tech Recent Developments
    Table 98. Mayo Clinic Laboratories Company Details
    Table 99. Mayo Clinic Laboratories Business Overview
    Table 100. Mayo Clinic Laboratories COVID-19 Diagnostic Testing Product
    Table 101. Mayo Clinic Laboratories Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 102. Mayo Clinic Laboratories Recent Developments
    Table 103. Chembio Diagnostics Company Details
    Table 104. Chembio Diagnostics Business Overview
    Table 105. Chembio Diagnostics COVID-19 Diagnostic Testing Product
    Table 106. Chembio Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 107. Chembio Diagnostics Recent Developments
    Table 108. Mount Sinai Laboratory Company Details
    Table 109. Mount Sinai Laboratory Business Overview
    Table 110. Mount Sinai Laboratory COVID-19 Diagnostic Testing Product
    Table 111. Mount Sinai Laboratory Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 112. Mount Sinai Laboratory Recent Developments
    Table 113. Ortho Clinical Diagnostics Company Details
    Table 114. Ortho Clinical Diagnostics Business Overview
    Table 115. Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Product
    Table 116. Ortho Clinical Diagnostics Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 117. Ortho Clinical Diagnostics Recent Developments
    Table 118. Zhejiang Orient Gene Biotech Company Details
    Table 119. Zhejiang Orient Gene Biotech Business Overview
    Table 120. Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Product
    Table 121. Zhejiang Orient Gene Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 122. Zhejiang Orient Gene Biotech Recent Developments
    Table 123. Innovita Biological Technology Company Details
    Table 124. Innovita Biological Technology Business Overview
    Table 125. Innovita Biological Technology COVID-19 Diagnostic Testing Product
    Table 126. Innovita Biological Technology Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 127. Innovita Biological Technology Recent Developments
    Table 128. Guangzhou Wondfo Biotech Company Details
    Table 129. Guangzhou Wondfo Biotech Business Overview
    Table 130. Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Product
    Table 131. Guangzhou Wondfo Biotech Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 132. Guangzhou Wondfo Biotech Recent Developments
    Table 133. Guangdong Hecin-Scientific Company Details
    Table 134. Guangdong Hecin-Scientific Business Overview
    Table 135. Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Product
    Table 136. Guangdong Hecin-Scientific Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 137. Guangdong Hecin-Scientific Recent Developments
    Table 138. Dynamiker Biotechnology (Tianjin) Company Details
    Table 139. Dynamiker Biotechnology (Tianjin) Business Overview
    Table 140. Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Product
    Table 141. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 142. Dynamiker Biotechnology (Tianjin) Recent Developments
    Table 143. ADVAITE Company Details
    Table 144. ADVAITE Business Overview
    Table 145. ADVAITE COVID-19 Diagnostic Testing Product
    Table 146. ADVAITE Revenue in COVID-19 Diagnostic Testing Business (2019-2024) & (US$ Million)
    Table 147. ADVAITE Recent Developments
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global COVID-19 Diagnostic Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global COVID-19 Diagnostic Testing Market Share by Type: 2023 VS 2030
    Figure 3. Nucleic Acid Testing Features
    Figure 4. Antibody Testing Features
    Figure 5. Global COVID-19 Diagnostic Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global COVID-19 Diagnostic Testing Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Scientific Research Case Studies
    Figure 9. COVID-19 Diagnostic Testing Report Years Considered
    Figure 10. Global COVID-19 Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global COVID-19 Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global COVID-19 Diagnostic Testing Market Share by Region: 2023 VS 2030
    Figure 13. Global COVID-19 Diagnostic Testing Market Share by Players in 2023
    Figure 14. Global Top COVID-19 Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Testing as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Diagnostic Testing Revenue in 2023
    Figure 16. North America COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
    Figure 18. North America COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
    Figure 19. North America COVID-19 Diagnostic Testing Market Share by Country (2019-2030)
    Figure 20. United States COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe COVID-19 Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
    Figure 24. Europe COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
    Figure 25. Europe COVID-19 Diagnostic Testing Market Share by Country (2019-2030)
    Figure 26. Germany COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China COVID-19 Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
    Figure 34. China COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
    Figure 35. Asia COVID-19 Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
    Figure 37. Asia COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
    Figure 38. Asia COVID-19 Diagnostic Testing Market Share by Region (2019-2030)
    Figure 39. Japan COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America COVID-19 Diagnostic Testing Market Share by Country (2019-2030)
    Figure 49. Brazil COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries COVID-19 Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Cellex Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 56. Abbott Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 57. Roche Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 58. BioMedomics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 59. BD Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 60. Henry Schein Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 61. Safecare Bio-Tech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 62. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 63. Chembio Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 64. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 65. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 66. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 67. Innovita Biological Technology Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 68. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 69. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 70. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 71. ADVAITE Revenue Growth Rate in COVID-19 Diagnostic Testing Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart